Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Nov;41(11):2466–2470. doi: 10.1128/aac.41.11.2466

Effects of moderate-dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and adverse reactions.

O Naderer 1, A N Nafziger 1, J S Bertino Jr 1
PMCID: PMC164146  PMID: 9371351

Abstract

The effects of a 10-day course of moderate-dose (10 mg/kg/day) or high-dose (20 mg/kg/day) trimethoprim therapy on serum creatinine, measured creatinine clearance, urinary creatinine excretion, and serum folate were studied in 20 healthy volunteers. Serum creatinine concentrations increased significantly during trimethoprim therapy, began to decrease near day 10, and returned to baseline during the washout phase at both dosage levels. At the same time, measured creatinine clearance and urine creatinine changed in the opposite direction. No clinical or statistical differences were noted between changes in the moderate- versus the high-dose phases. Serum folate concentration decreases during high-dose trimethoprim therapy were statistically significant. Adverse drug reactions in the two groups were statistically different during the first study period, with the high-dose group having a 75% incidence rate and the moderate-dose group having an 11% incidence rate (P < 0.02). Serum creatinine, measured creatinine clearance, and urinary creatinine excretion demonstrated statistically, but not clinically, significant changes during trimethoprim therapy. In addition, high-dose trimethoprim caused significantly more adverse drug reactions than moderate-dose trimethoprim in normal volunteers.

Full Text

The Full Text of this article is available as a PDF (152.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alappan R., Perazella M. A., Buller G. K. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Ann Intern Med. 1996 Feb 1;124(3):316–320. doi: 10.7326/0003-4819-124-3-199602010-00006. [DOI] [PubMed] [Google Scholar]
  2. Berg K. J., Gjellestad A., Nordby G., Rootwelt K., Djøseland O., Fauchald P., Mehl A., Narverud J., Talseth T. Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients. Nephron. 1989;53(3):218–222. doi: 10.1159/000185747. [DOI] [PubMed] [Google Scholar]
  3. Berglund F., Killander J., Pompeius R. Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man. J Urol. 1975 Dec;114(6):802–808. doi: 10.1016/s0022-5347(17)67149-0. [DOI] [PubMed] [Google Scholar]
  4. Caterson R. J., Collett P. V., Hood V. L., Duggin G. G., Horvath J. S., Johnson J. R., Sampson J., Tiller D. J. Trimethoprim/sulfamethoxazole and renal function in transplant patients. Clin Pharmacol Ther. 1978 May;23(5):553–557. doi: 10.1002/cpt1978235553. [DOI] [PubMed] [Google Scholar]
  5. Hughes W. T., LaFon S. W., Scott J. D., Masur H. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia. J Infect Dis. 1995 May;171(5):1295–1301. doi: 10.1093/infdis/171.5.1295. [DOI] [PubMed] [Google Scholar]
  6. Hughes W., Leoung G., Kramer F., Bozzette S. A., Safrin S., Frame P., Clumeck N., Masur H., Lancaster D., Chan C. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med. 1993 May 27;328(21):1521–1527. doi: 10.1056/NEJM199305273282103. [DOI] [PubMed] [Google Scholar]
  7. Kalowski S., Nanra R. S., Mathew T. H., Kincaid-Smith P. Deterioration in renal function in association with co-trimoxazole therapy. Lancet. 1973 Feb 24;1(7800):394–397. doi: 10.1016/s0140-6736(73)90251-1. [DOI] [PubMed] [Google Scholar]
  8. Kastrup J., Bartram R., Petersen P., Hansen J. M. Trimetoprims indvirkning på serum-digoksin og serum-kreatinin. Ugeskr Laeger. 1983 Jul 25;145(30):2286–2288. [PubMed] [Google Scholar]
  9. Kastrup J., Petersen P., Bartram R., Hansen J. M. The effect of trimethoprim on serum creatinine. Br J Urol. 1985 Jun;57(3):265–268. doi: 10.1111/j.1464-410x.1985.tb06340.x. [DOI] [PubMed] [Google Scholar]
  10. Leoung G. S., Mills J., Hopewell P. C., Hughes W., Wofsy C. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med. 1986 Jul;105(1):45–48. doi: 10.7326/0003-4819-105-1-45. [DOI] [PubMed] [Google Scholar]
  11. Medina I., Mills J., Leoung G., Hopewell P. C., Lee B., Modin G., Benowitz N., Wofsy C. B. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med. 1990 Sep 20;323(12):776–782. doi: 10.1056/NEJM199009203231202. [DOI] [PubMed] [Google Scholar]
  12. Myre S. A., McCann J., First M. R., Cluxton R. J., Jr Effect of trimethoprim on serum creatinine in healthy and chronic renal failure volunteers. Ther Drug Monit. 1987 Jun;9(2):161–165. doi: 10.1097/00007691-198706000-00006. [DOI] [PubMed] [Google Scholar]
  13. Roy M. T., First M. R., Myre S. A., Cacini W. Effect of co-trimoxazole and sulfamethoxazole on serum creatinine in normal subjects. Ther Drug Monit. 1982;4(1):77–79. doi: 10.1097/00007691-198204000-00011. [DOI] [PubMed] [Google Scholar]
  14. Sandberg T., Trollfors B. Effect of trimethoprim on serum creatinine in patients with acute cystitis. J Antimicrob Chemother. 1986 Jan;17(1):123–124. doi: 10.1093/jac/17.1.123-a. [DOI] [PubMed] [Google Scholar]
  15. Shouval D., Ligumsky M., Ben-Ishay D. Effect of co-trimoxazole on normal creatinine clearance. Lancet. 1978 Feb 4;1(8058):244–245. doi: 10.1016/s0140-6736(78)90486-5. [DOI] [PubMed] [Google Scholar]
  16. Stevens R. C., Laizure S. C., Sanders P. L., Stein D. S. Multiple-dose pharmacokinetics of 12 milligrams of trimethoprim and 60 milligrams of sulfamethoxazole per kilogram of body weight per day in healthy volunteers. Antimicrob Agents Chemother. 1993 Mar;37(3):448–452. doi: 10.1128/aac.37.3.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Stevens R. C., Laizure S. C., Williams C. L., Stein D. S. Pharmacokinetics and adverse effects of 20-mg/kg/day trimethoprim and 100-mg/kg/day sulfamethoxazole in healthy adult subjects. Antimicrob Agents Chemother. 1991 Sep;35(9):1884–1890. doi: 10.1128/aac.35.9.1884. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES